[HTML] nature.comFull View

[HTML][HTML] Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance

V Barbier, J Erbani, C Fiveash, JM Davies, J Tay… - Nature …, 2020 - nature.com
The endothelial cell adhesion molecule E-selectin is a key component of the bone marrow
hematopoietic stem cell (HSC) vascular niche regulating balance between HSC self …
被引用次数：139 相关文章

Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance

V Barbier, J Erbani, C Fiveash… - Nature …, 2020 - pubmed.ncbi.nlm.nih.gov
The endothelial cell adhesion molecule E-selectin is a key component of the bone marrow
hematopoietic stem cell (HSC) vascular niche regulating balance between HSC self …

Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance

V Barbier, J Erbani, C Fiveash… - Nature …, 2020 - ui.adsabs.harvard.edu
The endothelial cell adhesion molecule E-selectin is a key component of the bone marrow
hematopoietic stem cell (HSC) vascular niche regulating balance between HSC self …
[PDF] monash.edu

[PDF][PDF] Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance

V Barbier, J Erbani, C Fiveash, JM Davies, J Tay… - researchmgt.monash.edu
Results BM E-selectin expression increases during AML. E-selectin is a vascular adhesion
molecule expressed by endothelial cells following inflammation or injury 12. We found cell …
[HTML] nih.gov

[HTML][HTML] Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance

V Barbier, J Erbani, C Fiveash, JM Davies… - Nature …, 2020 - ncbi.nlm.nih.gov
The endothelial cell adhesion molecule E-selectin is a key component of the bone marrow
hematopoietic stem cell (HSC) vascular niche regulating balance between HSC self …

Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance

V Barbier, J Erbani, C Fiveash… - Nature …, 2020 - research.monash.edu
The endothelial cell adhesion molecule E-selectin is a key component of the bone marrow
hematopoietic stem cell (HSC) vascular niche regulating balance between HSC self …

Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance

V Barbier, J Erbani, C Fiveash, JM Davies… - Nature …, 2020 - ideas.repec.org
The endothelial cell adhesion molecule E-selectin is a key component of the bone marrow
hematopoietic stem cell (HSC) vascular niche regulating balance between HSC self …
[PDF] glycomimetics.com

[PDF][PDF] Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance

V Barbier, J Erbani, C Fiveash, JM Davies, J Tay… - glycomimetics.com
Results BM E-selectin expression increases during AML. E-selectin is a vascular adhesion
molecule expressed by endothelial cells following inflammation or injury 12. We found cell …

Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance.

V Barbier, J Erbani, C Fiveash, JM Davies… - Nature …, 2020 - europepmc.org
The endothelial cell adhesion molecule E-selectin is a key component of the bone marrow
hematopoietic stem cell (HSC) vascular niche regulating balance between HSC self …

Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance

V Barbier, J Erbani, C Fiveash… - Nature …, 2020 - econpapers.repec.org
The endothelial cell adhesion molecule E-selectin is a key component of the bone marrow
hematopoietic stem cell (HSC) vascular niche regulating balance between HSC self …